Proteomic Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245827

Publication Date:

October 21, 2024

Pages:

158

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Proteomic biomarkers are thus protein indicators of biological processes that are typically discovered through the analysis of a cell protein library in a diseased and/or nondiseased state.
The global market for Proteomic Biomarker was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The market in Asia Pacific is also growing rapidly during the forecast period owing to the increasing focus on precision medicine in the region and the growing burden of diseases such as cancer and cardiovascular diseases in the region.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Proteomic Biomarker, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Proteomic Biomarker by region & country, by Type, and by Application.
The Proteomic Biomarker market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proteomic Biomarker.
Market Segmentation
By Company
Abbott Laboratories
Agilent/Dako
Amprion
BasePair Biotechnologies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne
Bruker
C2N Diagnostics
Cepheid (Danaher)
Diadem Diagnostics
Eve Technologies
Fluidic Analytics
Fujirebio
Hybrigenics Services
Luminex Corp (DiaSorin)
NanoDx
Nautilus Biotechnology
Nicoya
Olink
Qiagen
Segment by Type:
Mass spectrometry
Chromatography
Blotting
Others
Segment by Application
Bio Industry
Medical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Proteomic Biomarker manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Proteomic Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Proteomic Biomarker in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Proteomic Biomarker Product Introduction
1.2 Global Proteomic Biomarker Market Size Forecast
1.3 Proteomic Biomarker Market Trends & Drivers
1.3.1 Proteomic Biomarker Industry Trends
1.3.2 Proteomic Biomarker Market Drivers & Opportunity
1.3.3 Proteomic Biomarker Market Challenges
1.3.4 Proteomic Biomarker Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Proteomic Biomarker Players Revenue Ranking (2023)
2.2 Global Proteomic Biomarker Revenue by Company (2019-2024)
2.3 Key Companies Proteomic Biomarker Manufacturing Base Distribution and Headquarters
2.4 Key Companies Proteomic Biomarker Product Offered
2.5 Key Companies Time to Begin Mass Production of Proteomic Biomarker
2.6 Proteomic Biomarker Market Competitive Analysis
2.6.1 Proteomic Biomarker Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Proteomic Biomarker Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mass spectrometry
3.1.2 Chromatography
3.1.3 Blotting
3.1.4 Others
3.2 Global Proteomic Biomarker Sales Value by Type
3.2.1 Global Proteomic Biomarker Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Proteomic Biomarker Sales Value, by Type (2019-2030)
3.2.3 Global Proteomic Biomarker Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Bio Industry
4.1.2 Medical Industry
4.1.3 Others
4.2 Global Proteomic Biomarker Sales Value by Application
4.2.1 Global Proteomic Biomarker Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Proteomic Biomarker Sales Value, by Application (2019-2030)
4.2.3 Global Proteomic Biomarker Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Proteomic Biomarker Sales Value by Region
5.1.1 Global Proteomic Biomarker Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Proteomic Biomarker Sales Value by Region (2019-2024)
5.1.3 Global Proteomic Biomarker Sales Value by Region (2025-2030)
5.1.4 Global Proteomic Biomarker Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Proteomic Biomarker Sales Value, 2019-2030
5.2.2 North America Proteomic Biomarker Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Proteomic Biomarker Sales Value, 2019-2030
5.3.2 Europe Proteomic Biomarker Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Proteomic Biomarker Sales Value, 2019-2030
5.4.2 Asia Pacific Proteomic Biomarker Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Proteomic Biomarker Sales Value, 2019-2030
5.5.2 South America Proteomic Biomarker Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Proteomic Biomarker Sales Value, 2019-2030
5.6.2 Middle East & Africa Proteomic Biomarker Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Proteomic Biomarker Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Proteomic Biomarker Sales Value
6.3 United States
6.3.1 United States Proteomic Biomarker Sales Value, 2019-2030
6.3.2 United States Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Proteomic Biomarker Sales Value, 2019-2030
6.4.2 Europe Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Proteomic Biomarker Sales Value, 2019-2030
6.5.2 China Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.5.3 China Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Proteomic Biomarker Sales Value, 2019-2030
6.6.2 Japan Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Proteomic Biomarker Sales Value, 2019-2030
6.7.2 South Korea Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Proteomic Biomarker Sales Value, 2019-2030
6.8.2 Southeast Asia Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Proteomic Biomarker Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Proteomic Biomarker Sales Value, 2019-2030
6.9.2 India Proteomic Biomarker Sales Value by Type (%), 2023 VS 2030
6.9.3 India Proteomic Biomarker Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Proteomic Biomarker Products, Services and Solutions
7.1.4 Abbott Laboratories Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Agilent/Dako
7.2.1 Agilent/Dako Profile
7.2.2 Agilent/Dako Main Business
7.2.3 Agilent/Dako Proteomic Biomarker Products, Services and Solutions
7.2.4 Agilent/Dako Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent/Dako Recent Developments
7.3 Amprion
7.3.1 Amprion Profile
7.3.2 Amprion Main Business
7.3.3 Amprion Proteomic Biomarker Products, Services and Solutions
7.3.4 Amprion Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.3.5 BasePair Biotechnologies Recent Developments
7.4 BasePair Biotechnologies
7.4.1 BasePair Biotechnologies Profile
7.4.2 BasePair Biotechnologies Main Business
7.4.3 BasePair Biotechnologies Proteomic Biomarker Products, Services and Solutions
7.4.4 BasePair Biotechnologies Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.4.5 BasePair Biotechnologies Recent Developments
7.5 Beckman Coulter Diagnostics
7.5.1 Beckman Coulter Diagnostics Profile
7.5.2 Beckman Coulter Diagnostics Main Business
7.5.3 Beckman Coulter Diagnostics Proteomic Biomarker Products, Services and Solutions
7.5.4 Beckman Coulter Diagnostics Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.5.5 Beckman Coulter Diagnostics Recent Developments
7.6 Becton, Dickinson and Company
7.6.1 Becton, Dickinson and Company Profile
7.6.2 Becton, Dickinson and Company Main Business
7.6.3 Becton, Dickinson and Company Proteomic Biomarker Products, Services and Solutions
7.6.4 Becton, Dickinson and Company Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.6.5 Becton, Dickinson and Company Recent Developments
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Profile
7.7.2 Bio-Rad Laboratories, Inc. Main Business
7.7.3 Bio-Rad Laboratories, Inc. Proteomic Biomarker Products, Services and Solutions
7.7.4 Bio-Rad Laboratories, Inc. Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories, Inc. Recent Developments
7.8 Bio-Techne
7.8.1 Bio-Techne Profile
7.8.2 Bio-Techne Main Business
7.8.3 Bio-Techne Proteomic Biomarker Products, Services and Solutions
7.8.4 Bio-Techne Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Techne Recent Developments
7.9 Bruker
7.9.1 Bruker Profile
7.9.2 Bruker Main Business
7.9.3 Bruker Proteomic Biomarker Products, Services and Solutions
7.9.4 Bruker Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.9.5 Bruker Recent Developments
7.10 C2N Diagnostics
7.10.1 C2N Diagnostics Profile
7.10.2 C2N Diagnostics Main Business
7.10.3 C2N Diagnostics Proteomic Biomarker Products, Services and Solutions
7.10.4 C2N Diagnostics Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.10.5 C2N Diagnostics Recent Developments
7.11 Cepheid (Danaher)
7.11.1 Cepheid (Danaher) Profile
7.11.2 Cepheid (Danaher) Main Business
7.11.3 Cepheid (Danaher) Proteomic Biomarker Products, Services and Solutions
7.11.4 Cepheid (Danaher) Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.11.5 Cepheid (Danaher) Recent Developments
7.12 Diadem Diagnostics
7.12.1 Diadem Diagnostics Profile
7.12.2 Diadem Diagnostics Main Business
7.12.3 Diadem Diagnostics Proteomic Biomarker Products, Services and Solutions
7.12.4 Diadem Diagnostics Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.12.5 Diadem Diagnostics Recent Developments
7.13 Eve Technologies
7.13.1 Eve Technologies Profile
7.13.2 Eve Technologies Main Business
7.13.3 Eve Technologies Proteomic Biomarker Products, Services and Solutions
7.13.4 Eve Technologies Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.13.5 Eve Technologies Recent Developments
7.14 Fluidic Analytics
7.14.1 Fluidic Analytics Profile
7.14.2 Fluidic Analytics Main Business
7.14.3 Fluidic Analytics Proteomic Biomarker Products, Services and Solutions
7.14.4 Fluidic Analytics Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.14.5 Fluidic Analytics Recent Developments
7.15 Fujirebio
7.15.1 Fujirebio Profile
7.15.2 Fujirebio Main Business
7.15.3 Fujirebio Proteomic Biomarker Products, Services and Solutions
7.15.4 Fujirebio Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.15.5 Fujirebio Recent Developments
7.16 Hybrigenics Services
7.16.1 Hybrigenics Services Profile
7.16.2 Hybrigenics Services Main Business
7.16.3 Hybrigenics Services Proteomic Biomarker Products, Services and Solutions
7.16.4 Hybrigenics Services Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.16.5 Hybrigenics Services Recent Developments
7.17 Luminex Corp (DiaSorin)
7.17.1 Luminex Corp (DiaSorin) Profile
7.17.2 Luminex Corp (DiaSorin) Main Business
7.17.3 Luminex Corp (DiaSorin) Proteomic Biomarker Products, Services and Solutions
7.17.4 Luminex Corp (DiaSorin) Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.17.5 Luminex Corp (DiaSorin) Recent Developments
7.18 NanoDx
7.18.1 NanoDx Profile
7.18.2 NanoDx Main Business
7.18.3 NanoDx Proteomic Biomarker Products, Services and Solutions
7.18.4 NanoDx Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.18.5 NanoDx Recent Developments
7.19 Nautilus Biotechnology
7.19.1 Nautilus Biotechnology Profile
7.19.2 Nautilus Biotechnology Main Business
7.19.3 Nautilus Biotechnology Proteomic Biomarker Products, Services and Solutions
7.19.4 Nautilus Biotechnology Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.19.5 Nautilus Biotechnology Recent Developments
7.20 Nicoya
7.20.1 Nicoya Profile
7.20.2 Nicoya Main Business
7.20.3 Nicoya Proteomic Biomarker Products, Services and Solutions
7.20.4 Nicoya Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.20.5 Nicoya Recent Developments
7.21 Olink
7.21.1 Olink Profile
7.21.2 Olink Main Business
7.21.3 Olink Proteomic Biomarker Products, Services and Solutions
7.21.4 Olink Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.21.5 Olink Recent Developments
7.22 Qiagen
7.22.1 Qiagen Profile
7.22.2 Qiagen Main Business
7.22.3 Qiagen Proteomic Biomarker Products, Services and Solutions
7.22.4 Qiagen Proteomic Biomarker Revenue (US$ Million) & (2019-2024)
7.22.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Proteomic Biomarker Industrial Chain
8.2 Proteomic Biomarker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Proteomic Biomarker Sales Model
8.5.2 Sales Channel
8.5.3 Proteomic Biomarker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Agilent/Dako
Amprion
BasePair Biotechnologies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne
Bruker
C2N Diagnostics
Cepheid (Danaher)
Diadem Diagnostics
Eve Technologies
Fluidic Analytics
Fujirebio
Hybrigenics Services
Luminex Corp (DiaSorin)
NanoDx
Nautilus Biotechnology
Nicoya
Olink
Qiagen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂